We are creating an "open source" movement for leukemia & medical technology research. No patents, no proprietary data, no proprietary code. We want to change how the medical system works, and provide our research and technology open and free.
Our first research project, the Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project, was created in 2018 by Adam Milton-Barker after his grandfather, Peter Moss, was diagnosed with Acute Myeloid Leukemia (AML), given a few weeks to live. The immediate challenge for Peter's family was finding information and advice that could help them understand how to live with the disease. With AML, there are no known warning signs, so early detection is very hard, if not impossible. In Peter's case, the disease was completely missed in a standard blood test 1 month before being diagnosed with AML.
Adam has a number of years experience developing computer vision and natural language understanding applications focused on real world applications, and had previously created a Computer Vision (Artificial Intelligence) project to detect a form of breast cancer known as Invasive Ductal Carcinoma. BreastCancerAI was where Adam's experience began with using modern technologies for medical purposes. He wanted to see if he could use that experience to build a classifier to detect AML.
Unlike finding open data for breast cancer, computer vision datasets for Acute Myeloid Leukemia are hard to come across. A reply to a post made in Artificial Intelligence & Deep Learning (AIDL) group on Facebook directed the team to the Acute Lymphoblastic Leukemia Image Database for Image Processing dataset by Fabio Scotti - Associate Professor Dipartimento di Informatica @ Università degli Studi di Milano. This dataset became the foundation of our leukemia research since 2018.
During 2019, the project attracted researchers and developers from throughout the globe and are we started a free student program that allows students to work on real world medical problems in the medical industry.
Through the Intel Software Innovators Program, we were given the opportunity to talk about and present our technology at several events throughout Europe, including Embedded World 2019, Nuremberg, Germany, Intel Dev Affinity Day 2019, Munich, Germany and Codemotion 2019, Madrid, Spain.
Estela Cabezas joined our team in 2019 as a student on our student program and presented our project at Embedded World 2019, Intel Dev Affinity Day 2019 and Codemotion 2019. Estela was able to use our project as case study in her thesis: Applied Analytics for clinical decision support and not long after joined our team as a permanent team member.
In August 2019, after battling AML for one day short of a year since being terminally diagnosed, Peter Moss sadly passed away. In his memory the team committed to the fight against leukemia & other blood cancers in his name.
Our goal remains to continue providing researchers, students, developers and medical professionals a way to contribute and collaborate towards finding ways to battle Leukemia with technology, as well as giving the public a platform to find open information about leukemia, and speak with our team and professionals.
For just over a year the team had volunteered their free time to the Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project, and we had made great progress in that time. We now have a talented, global team of volunteers, but to really make things happen, we needed full-time dedicated members. The next natural step in our journey was to register as a non profit and allow some of our team to work full & part time. In January 2020, Peter Moss Leukemia AI Research Association website was created in the anticipation of forming a non-profit: Asociacion De Investigacion En Inteligencia Artificial Para La Leucemia Peter Moss.
In June 2020, we finally achieved our goal of becoming a non-profit association, dedicated to fighting Leukemia with open-source information and technology. Led by Adam Milton-Barker, Virginia Mijes Martin & Javier Lopez Alonso, Asociacion De Investigacion En Inteligencia Artificial Para La Leucemia Peter Moss emerged from the flames of the COVID-19 pandemic. We now have an amazing team of 14 people, all volunteering their time to the fight against Leukemia and COVID-19. It is an exciting time for our team, and we are one step closer to having opening our Leukemia Research Hospital.
In January 2020 we started a crowdfunding campaign on GoFundMe, the donations from this crowdfunding campaign have helped pay for services/software and hardware required for our projects, and to help raise funds to take on staff. As we are now an association, this campaign will become a personal campaign to help Adam raise funds to allow him to continue as a full time volunteer until we raise enough money for salaries or become funded. Please follow/share our mission/campaign using the following link: Help to continue volunteering full time
The Peter Moss Acute Myeloid & Lymphoblastic Leukemia AI Research Project will always hold a special place in our hearts. Peter's fight with Acute Myeloid Leukemia inspired the research project, and in his name we will continue to work on open source technologies to help battle and understand Acute Myeloid Leukemia. We will be continuing to build the research project and team, with the goals of onboarding more medical professionals. We now have access to a couple of Acute Myeloid Leukemia Datasets, and are planning our first Acute Myeloid Leukemia projects, AML-Tensorflow-2020 and AML-Genomics-2020.
Our Association relies on volunteers to help us build and validate our technology. If you would like to join our team as a professional volunteer, please use the form on our Professional Volunteer Application page.